Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomedical Tissue Technologies was an Australian medical device company focused on fracture-healing products rather than a drug-development biotech pipeline. The company marketed the Melmak low-intensity pulsed ultrasound (LIPUS) system, a home-use, noninvasive device intended to support healing of fresh fractures and established non-unions. Available evidence indicates the business operated from the Sydney, Australia area and was founded in 2008, with product materials also listing Auburn, New South Wales as an operating address. Secondary company databases describe the company as deadpooled/inactive, suggesting it is no longer an operating business. The company appears to have been a niche orthopedic device player rather than a therapeutics or platform life sciences company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomedical Tissue Technologies.